An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States

Transplantation

Volumn 87, Issue 7, 2009, Pages 1019-1026

  Dharnidharka, Vikas R ^a,d   Cherikh, Wida S ^b   Abbott, Kevin C ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VCU Office of Research   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d Division of Pediatric Nephrology   (United States)

Author keywords

BK virus; Immunosuppression; Infection; Kidney transplantation; Polyoma

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; DACLIZUMAB; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BK VIRUS; BK VIRUS ALLOGRAFT NEPHROPATHY; CHILD; DATA ANALYSIS; DATA BASE; FEMALE; HUMAN; INCIDENCE; INFANT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; VIRUS INFECTION; ALLOTRANSPLANTATION; CADAVER; CLINICAL TRIAL; DONOR; IMMUNOLOGY; MULTICENTER STUDY; PATHOLOGY; POSTOPERATIVE COMPLICATION; STATISTICS; TIME; VIROLOGY;

BK VIRUS; CADAVER; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TUMOR VIRUS INFECTIONS; UNITED STATES;

EID: 65549108756     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819cc383     Document Type: Article

References (28)

1. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611.
2. Dall A, Hariharan S. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 2008; 3(suppl 2): S68.
3. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med 2000; 342: 1361.
4. Bohl DL, Brennan DC. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2007; 2(suppl 1): S36.
5. Dharnidharka VR, Harmon WE. Management of pediatric postrenal transplantation infections. Semin Nephrol 2001; 21: 521.
6. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488.
7. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309.
8. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145.
9. Drachenberg CB, Papadimitriou JC, Mann D, et al. Negative impact of human leukocyte antigen matching in the outcome of polyomavirus nephropathy. Transplantation 2005; 80: 276.
10. Yeo FE, Yuan CM, Swanson SJ, et al. The prevalence of BK polyomavirus infection in outpatient kidney transplant recipients followed in a single center. Clin Transplant 2008; 22: 522.
11. Howell DN, Smith SR, Butterly DW, et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation 1999; 68: 1279.
12. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918.
13. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
14. Smith JM, Dharnidharka VR, Talley L, et al. BK virus nephropathy in pediatric renal transplant recipients: An analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2007; 2: 1037.
15. Khamash HA, Wadei HM, Mahale AS, et al. Polyomavirus-associated nephropathy risk in kidney transplants: The influence of recipient age and donor gender. Kidney Int 2007; 71: 1302.
16. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
17. Cherikh WS, KauffmanHM,McBride MA, et al. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation 2003; 76: 1289.
18. Johnson SR, Cherikh WS, Kauffman HM, et al. Retransplantation after post-transplant lymphoproliferative disorders: An OPTN/UNOS database analysis. Am J Transplant 2006; 6: 2743.
19. Dharnidharka VR, Tejani AH, Ho PL, et al. Post-transplant lymphoproliferative disorder in the United States: Young Caucasian males are at highest risk. Am J Transplant 2002; 2: 993.
20. Abbott KC, Oliver JD III, Hypolite I, et al. Hospitalizations for bacterial septicemia after renal transplantation in the United States. Am J Nephrol 2001; 21: 120.
21. Drachenberg CB, Beskow CO, Cangro CB, et al. Human polyoma virus in renal allograft biopsies: Morphological findings and correlation with urine cytology. Hum Pathol 1999; 30: 970.
22. Awadalla Y, Randhawa P, Ruppert K, et al. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant 2004; 4: 1691.
23. Opelz G. Impact of HLA compatibility on survival of kidney transplants from unrelated live donors. Transplantation 1997; 64: 1473.
24. Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 2213.
25. Acott PD, Hirsch HH. BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol 2007; 22: 1243.
26. Thomas A, Dropulic LK, Rahman MH, et al. Ureteral stents: A novel risk factor for polyomavirus nephropathy. Transplantation 2007; 84: 433.
27. Ramos E, Vincenti F, LuWX,et al. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation 2004; 77: 131.
28. Mylonakis E, Goes N, Rubin RH, et al. BK virus in solid organ transplant recipients: An emerging syndrome. Transplantation 2001; 72: 1587.